Chronic atrophic gastritis (CAG) is a digestive system disease with a high prevalence and a high cancer rate developed by a combination of factors. Its pathogenesis is complex. There is currently no exact name of the disease in traditional Chinese medicine and modern medicine also lacks excellent treatments. Therefore, it is very important to explore the etiology and pathogenesis of CAG, understand its prognosis and prognosis, and prevent cancer. Based on ancient books and classics and researches on CAG in recent years, this paper summarizes the pathogenesis of this disease as "deficiency", "stagnation" and " blood stasis", in order to provide a theoretical basis for the comprehensive clinical treatment of CAG.

Chen Chen, Zhao Weihan, Qiu Penghui, Luo Xingyu. On the pathogenesis characteristics of chronic atrophic gastritis from the perspective of deficiency, stagnation and blood stasis. Academic Journal of Medicine & Health Sciences (2022) Vol. 3, Issue 3: 17-22. https://doi.org/10.25236/AJMHS.2022.030304.

[1] Marques-Silva L, Areia M, Elvas L, et al.Prevalence of gastric precancerous conditions: a systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2014, 26(4):378-387. 

[2] Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994[J]. Am J Surg Pathol, 1996, 20(10):1161-1181. 

[3] ZHENG Jiayi, ZHAO Ziming, PAN Huafeng, et al. Pathology and ultrastructure study of gastric mucosal lesions in rats with spleen deficiency in gastric precancerous lesions[J].Chinese Journal of Traditional Chinese Medicine,2018,33(05):1730-1735.

[4] CHENG Ruodong, CUI Yiming, CHEN Lu, et al. Study on the pattern of precancerous lesions of chronic atrophic gastritis based on logistic regression model[J].Chinese Journal of Traditional Chinese Medicine,2018,33(08):3623-3626.

[5] ZHU Fangshi, JI Jianmin, WANG Liangjing. Clinical classification of atrophic gastritis[J]. World Journal of Chinese Digestion,2003(06):844-846.

[6] DAI Erqing, YANG Nan, SHEN Zhihong, et al.Correlation between TCM symptom type and gastroscopic and pathological image in 64 cases of chronic atrophic gastritis[J]. Liaoning Journal of Traditional Chinese Medicine,2016,43(03):458-461.

[7] Toh BH. Pathophysiology and laboratory diagnosis of pernicious anemia. Immunol Res. 2017 Feb; 65(1):326-330. 

[8] Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013 Sep; 10(9):529-541. 

[9] Faber, K.K. Achylia Gastrica mit Anamie[German].Medizinische Klinik 5,1310–1325(1909).

[10] Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, Lahad A. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica. 2005 May; 90(5):585-595. 

[11] Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006 Feb 15; 107(4):1673-1679. 

[12] Ha E, Bae JH. Zinc transporter SLC39A11 polymorphisms are associated with chronic gastritis in the Korean population: the possible effect on spicy food intake[J]. Nutr Res, 2018, 57:78-85. 

[13] Setiawan VW, Zhang ZF, Yu GP, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer[J]. Int J Cancer, 2001, 92(4):600-604. 

[14] Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies[J]. Nutr Cancer, 2005, 53(1):1-10. 

[15] Takezaki T, Gao CM, Wu JZ, et al. Dietary protective and risk factors for esophageal and stomach cancers in a low-epidemic area for stomach cancer in Jiangsu Province, China: comparison with those in a high-epidemic area[J]. Jpn J Cancer Res, 2001, 92(11):1157-1165.

[16] Joossens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group[J]. Int J Epidemiol, 1996, 25(3):494-504.

[17] Gonzalez CA, Riboli E. Diet and cancer prevention: where we are, where we are going[J]. Nutr Cancer, 2006, 56(2):225-231. 

[18] Shinozaki K, Kamada T, Sugiu K, et al. High-protein diet suppresses corpus atrophic gastritis in Helicobacter pylori infected Mongolian gerbils[J]. Nutr Cancer, 2010, 62(8):1067-1073. 

[19] Psychiatric Branch of Chinese Medical Association. CCMD-3 Chinese classification and diagnostic criteria for mental disorders[M]. 3 edition.Jinan: Shandong Science and Technology Press,2001: 83-91． 

[20] ZHANG Xin, HU Dongqing, ZHOU Xiaofeng, et al. Progress in diagnosis and treatment of chronic atrophic gastritis with depression and anxiety[J]. Shanxi Traditional Chinese Medicine,2017,33(12):55-57.

[21] CHEN Zehui, YANG Jinxiang, HAN Haihai, et al.Exploration of Chinese constitution types in 258 patients with chronic atrophic gastritis[J]. World Journal of Integrative Medicine,2018,13(07):973-976.

[22] Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention[J]. Cancer Res, 1992, 52(24): 6735-6740.

[23] YE Fujun, YANG Yuxue, MENG Yimin. Research on different pathological changes and Helicobacter pylori infection under gastroscopy in chronic atrophic gastritis[J]. Contemporary medicine, 2019, 25(07): 97-99.

[24] YANG Yuxia, MA Lili, GAO Yan, et al.Relationship between Hp infection and expression of MUC2, MUC5AC, MUC6 and CD10 in gastric cancer and gastric precancerous tissues[J/OL].Chinese Journal of Hospital Infectology,2022(05):721-725.

[25] Abdel-Salam OM, Czimmer J, Debreceni A, et al. Gastric mucosal integrity: gastric mucosal blood flow and microcirculation[J]. An overview. J Physiol Paris, 2001, 95(1-6):105-127.

[26] Chiou SK, Moon WS, Jones MK, et al. Survivin expression in the stomach: implications for mucosal integrity and protection[J]. Biochem Biophys Res Commun, 2003, 305(2):374-379. 

[27] Chiou SK, Tanigawa T, Akahoshi T, et al. Survivin: a novel target for indomethacin-induced gastric injury[J]. Gastroenterology, 2005, 128(1):63-73. 

[28] Chiou SK, Jones MK, Tarnawski AS. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond[J]. Med Sci Monit, 2003, 9(4):25-29.